Pakistan is hit by a shortage of anti-tuberculosis drugsBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2510 (Published 03 May 2016) Cite this as: BMJ 2016;353:i2510
- Abdul Nafey Kazi,
- Hafsa Mohiuddin
- Karachi, Pakistan
Pakistan is facing a severe shortage of drugs to treat tuberculosis (TB)—most notably ethambutol and pyrazinamide which are used to treat complex cases—because the government and the pharmaceutical industry have not been able to come to an agreement over pricing.
Most patients with TB are treated with a fixed dose combination available free under the Directly Observed Treatment, Short Course (DOTS) programme, but more complex cases need treatment …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial